Comparing the current results to its competitors, Shockwave Medical Inc reported Revenue increase in the 1 quarter 2024 by 35.72 % year on year. The sales growth was above Shockwave Medical Inc 's competitors' average revenue growth of 4.69 %, achieved in the same quarter.
Shockwave Medical Inc Net Income in the 1 quarter 2024 grew year on year by 41.46%, while most of its competitors have experienced a contraction in net income by -8.98 %.
Shockwave Medical Inc 's Comment on Competition and Industry Peers
The company operates in the cardiovascular medical device industry, which is highly competitive. Its competitors include large, well-capitalized firms such as Boston Scientific Corporation, Medtronic plc, Philips N.V., and Abbott Laboratories. These competitors possess advantages such as greater name recognition, broader relationships with healthcare professionals, more established distribution networks, additional product lines, and the capacity to offer discounts or incentives. The company also faces competition from smaller medical device companies with limited product ranges.
Strong sales growth of 35.72 % in Overall company contributed to Shockwave Medical Inc increase in total revenue by 35.72 % Shockwave Medical Inc improved its market share in this segment, to approximately 0.53 %.
Cardiovascular Systems Inc operates a business model focused on providing innovative medical technologies and solutions for the treatment of cardiovascular diseases.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.
Atricure Inc is a medical device company that focuses on developing, manufacturing, and selling innovative surgical solutions for the treatment of cardiac arrhythmias and other heart-related conditions.
Sources:
Shockwave Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Shockwave Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
